Lisa J Gould, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Fogg Rd, Weymouth, MA 02190 Phone: 781-624-8000 |
Dr. Benjamin Powell Christian, M.D. Plastic Surgery - Surgery of the Hand Medicare: Accepting Medicare Assignments Practice Location: 51 Performance Dr, Weymouth, MA 02189 Phone: 781-624-4915 |
Frank R Virnelli, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 15 Dix St, Winchester, MA 01890 Phone: 781-729-0947 Fax: 781-729-3569 |
Dr. Trung Le, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 123 Summer St, Suite 570n, Worcester, MA 01608 Phone: 508-368-3199 Fax: 508-368-3902 |
Jorge A Conejero, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: Umass Medical School, 55 Lake Avenue North, Worcester, MA 01655 Phone: 508-334-1000 |
Craig Rowin, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 281 Lincoln St, Medical Staff Svcs, Worcester, MA 01605 Phone: 508-334-8015 |
Natalie M. Godfrey, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 123 Summer St Ste 320s, Worcester, MA 01608 Phone: 508-964-5580 Fax: 508-368-3143 |
David C. Kim, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 123 Summer St, Worcester, MA 01608 Phone: 508-368-3140 Fax: 508-368-3196 |
News Archive
As part of Janssen's commitment to raising awareness of blood cancer, supporting patients with the condition and their families, Janssen has today launched the Make Blood Cancer Visible campaign.
Orexo AB has announced that its partner, UK-based international specialty pharmaceutical company ProStrakan Group plc, has submitted the New Drug Application (NDA) for Abstralâ„¢ (for the treatment of breakthrough cancer pain in opioid-tolerant patients) to the US Food and Drug Administration (FDA).
A Florida State University researcher is examining how the polyphenol compounds found in blackberries could be used to help fight the buildup of artery plaque.
After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study by researchers at UC San Francisco.
The study, published in the June 26 issue of the British journal The Lancet, is the third recently issued by NIAID that describes a promising candidate vaccine against SARS.
› Verified 1 days ago